An official website of the United States government
NIH Guide: Weekly Index for May 28, 2021
Weekly NIH Funding Opportunities and Notices
May 28, 2021
General Notices
-
Notice of Pre-Application Webinar for RFA-AR-21-015 and RFA-AR-21-016
(NOT-AR-21-017)National Institute of Arthritis and Musculoskeletal and Skin Diseases
-
Notice of Pre-Application Webinar for NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed)
(NOT-DK-21-021)National Institute of Diabetes and Digestive and Kidney Diseases
-
New Receipt Date and Change in Cost Match Requirement for Commercial Fishing Occupational Safety Training Project Grants (T03)
(NOT-OH-21-009)National Institute for Occupational Safety and Health
-
New Receipt Date and Change in Cost Match Requirement for Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)
(NOT-OH-21-010)National Institute for Occupational Safety and Health
-
Notice Announcing Data Generation Projects for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (OT2) Other Transaction Opportunity Announcement
(NOT-RM-21-029)Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
-
Notice of Correction to RFA-CA-20-031, Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)
(NOT-CA-21-082)National Cancer Institute
-
Notice of Early Termination of RFA-DA-22-002, "Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)"
(NOT-DA-21-058)National Institute on Drug Abuse
-
Notice to Extend the Application Due Date for RFA-FD-21-030 - "Strategies that Support Global Food Safety (U01) Clinical Trial Not Allowed"
(NOT-FD-21-015)Food and Drug Administration
-
Notice of Change to the Instructions for Appendices in PAR-21-026 "Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)"
(NOT-GM-21-040)National Institute of General Medical Sciences
-
Notice of Change to the Instructions for Appendices in PAR-21-146 "Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)"
(NOT-GM-21-041)National Institute of General Medical Sciences
-
Notice of Change to the Instructions for Appendices in PAR-19-299 "Bridges to the Baccalaureate Research Training Program (T34)"
(NOT-GM-21-042)National Institute of General Medical Sciences
-
Notice of Change to the Instructions for Appendices in PAR-19-366 "Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed)"
(NOT-GM-21-043)National Institute of General Medical Sciences
-
Notice of Change to the Instructions for Appendices in PAR-20-066 "Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed)"
(NOT-GM-21-044)National Institute of General Medical Sciences
-
Notice of Change to the Instructions for Appendices in PAR-20-213 "National Institute of General Medical Sciences Predoctoral Institutional Research Training Grant (T32 - Clinical Trial Not Allowed)"
(NOT-GM-21-046)National Institute of General Medical Sciences
-
Notice of Change to the Instructions for Appendices in PAR-21-025 "Initiative for Maximizing Student Development (IMSD) (T32 - Clinical Trial Not Allowed)"
(NOT-GM-21-047)National Institute of General Medical Sciences
-
Notice of Change to the Instructions for Appendices in PAR-21-147 "Maximizing Access to Research Careers (T34)"
(NOT-GM-21-048)National Institute of General Medical Sciences
-
Notice of Correction to Application Instructions and Revision of Due Date for RFA MD-21-007 "Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)"
(NOT-MD-21-024)National Institute on Minority Health and Health Disparities
-
Notice of Correction to Key Dates of RFA-MH-21-230, "Pilot Effectiveness Trials of Interventions for Preschoolers with ADHD (R34 Clinical Trial Required)"
(NOT-MH-21-295)National Institute of Mental Health
-
Notice of Change in Application Type for BRAIN Initiative: Team-Research BRAIN Circuit Programs TeamBCP
(NOT-NS-21-065)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences Research
-
Notice of Correction to Funding Opportunity Description for PAR-21-237 "NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)"
(NOT-NS-21-071)National Institute of Neurological Disorders and Stroke
-
Notice of Correction and the Change of the Receipt Date for PAR-21-125 Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed); PAR-21-126 High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed); PAR-21-127 Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
(NOT-OD-21-136)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
-
Notice to Extend the Response Date for NOT-TR-21-027, RFI: Facilitating the Early Diagnosis and Equitable Delivery of Gene-Targeted Therapies to Individuals with Rare Diseases
(NOT-TR-21-029)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed)
(NOT-CA-21-081)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for SPARC Human Open Research Neural Engineering Technology (HORNET) Initiative (U41 Clinical Trial Optional)
(NOT-RM-21-023)Office of Strategic Coordination (Common Fund)
Notices of Special Interest
-
Notice of Special Interest (NOSI): Reduction of Sudden Unexpected Infant Death and Sudden Infant Death Syndrome
(NOT-HD-21-032)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Special Interest (NOSI): Administrative Supplements to NIMHD Awards for Research on HIV/AIDS in Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional)
(NOT-MD-21-020)National Institute on Minority Health and Health Disparities
-
Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborative HIV/AIDS Research at NIMHD Research Centers in Minority Institutions (RCMI)
(NOT-MD-21-023)National Institute on Minority Health and Health Disparities
Funding Opportunities
-
Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)
(PA-21-232)National Institute on Minority Health and Health DisparitiesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Eye InstituteOffice of Research on Women's HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)
(PAR-21-217)National Institute on AgingApplication Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is August 8, 2021.
-
NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31)
(PAR-21-218)National Institute on AgingApplication Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is August 8, 2021.
-
NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed)
(PAR-21-220)National Institute on AgingApplication Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021.
-
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)
(PAR-21-230)John E. Fogarty International CenterNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthOffice of Disease PreventionApplication Receipt Date(s): Multiple dates, see announcement.
-
Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed)
(RFA-DA-22-005)National Institute on Drug AbuseApplication Receipt Date(s): October 14, 2021
-
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed)
(RFA-DA-22-007)National Institute on Drug AbuseApplication Receipt Date(s): October 14, 2021
-
Assessing the Effects of Cannabinoids on HIV-Associated Persistent Inflammation (R01 Clinical Trial Optional)
(RFA-DA-22-012)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required)
(RFA-DA-22-024)National Institute on Drug AbuseApplication Receipt Date(s): October 14, 2021
-
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Basic Experimental Studies with Humans Required)
(RFA-DA-22-030)National Institute on Drug AbuseApplication Receipt Date(s): October 14, 2021
-
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
(RFA-HL-22-010)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): October 14, 2021, February 11, 2022, October 13, 2022, February 14, 2023, October 13, 2023, February 13, 2024, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
(RFA-HL-22-011)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): October 14, 2021, February 11, 2022, October 13, 2022, February 14, 2023, October 13, 2023, February 13, 2024, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R01 Clinical Trial Optional)
(RFA-MH-21-225)National Institute of Mental HealthNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Not Applicable
-
Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R21 Clinical Trial Optional)
(RFA-MH-21-226)National Institute of Mental HealthNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Not Applicable
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: January 25, 2025
For technical issues E-mail OER Webmaster